
NBT Business Roundtable 2012
|
Sponsored by
 |
Nutraceuticals: An Industry in Transition
As nutra becomes ever-more like Big Pharma, and prevention takes the lead from treatment, the functional food sector is undergoing unprecedented change, with the spotlight being placed on quality, purity and sustainability. What does the nutraceutical industry need to do to remain viable and keep the pharma wolf from its doors?
Topics for Debate
Purity and Quality
- Dry Labbing
- Botanical Adulteration
Sustainability
- Global sourcing issues
- Marine sustainability: facts and fiction
IP and Litigation: Is the Nutraceutical Industry Already Getting Litigious?
The Challenge to Pharma
- Accelerated absorption of antioxidants from fish-based omega-3s
- Antiageing and inflammation reduction
- The Legal Status of Probiotic Health Claims in Europe
Exclusive Roundtable
Networking Break Sponsor

Top Table
- Moderator, Ewa Hudson, Head of Health and Wellness Research, Euromonitor
- Dr Alfred Jenssen, Sanki Mayor Innovation Center, Tokyo, Japan
- Dr Emiri Nishi, Ninapharm, Japan
- Dr Paul Berryman, Chief Executive at Leatherhead Food Research, UK
- George Pontiakos, President/CEO of BI Nutraceuticals, USA
- Adam Ismail, Exec Director, GOED, USA
- George Paraskevakos, President, International Probiotics Association, Switzerland
Contact us for more information >>
See details and a video of the Roundtable 2011 >> |